zoledronic acid has been researched along with bazedoxifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukawa, T; Kamiya, S; Wada, S | 1 |
| Silverman, SL | 1 |
2 review(s) available for zoledronic acid and bazedoxifene
| Article | Year |
|---|---|
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Drug Design; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Indoles; Organometallic Compounds; Osteoporosis; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Zoledronic Acid | 2008 |
New therapies for osteoporosis: zoledronic acid, bazedoxifene, and denosumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Indoles; Male; Osteoporosis; RANK Ligand; Risk Factors; Treatment Outcome; Zoledronic Acid | 2009 |